References
- Polack FP, Thomas SJ, Kitchin N, et al. Safety and efficacy of the BNT162b2 mRNA Covid-19 vaccine. N Engl J Med. 2020;383:2603–2615. doi:10.1056/NEJMoa2034577.
- Ishay Y, Kenig A, Tsemach-Toren T, et al. Autoimmune phenomena following SARS-CoV-2 vaccination. Int Immunopharmacol. 2021;99:107970. doi:10.1016/j.intimp.2021.107970.
- Rothova A, de Groot JD, Mudrikova T. Reactivation of acute retinal necrosis after flu H1N1 vaccination. Br J Ophthalmol. 2011;95:291. doi:10.1136/bjo.2010.185983.
- Chen RI, Deaner JD, Srivastava SK, et al. Acute retinal necrosis following recombinant subunit varicella-zoster virus vaccine. Am J Ophthalmol Case Rep. 2020;20:100962. doi:10.1016/j.ajoc.2020.100962.
- Heath G, Depledge DP, Brown JR, et al. Acute retinal necrosis caused by the zoster vaccine virus. Clin Infect Dis. 2017;65:2122–2125. doi:10.1093/cid/cix683.
- Psichogiou M, Samarkos M, Mikos N, et al. Reactivation of varicella zoster virus after vaccination for SARS-CoV-2. Vaccines (Basel). 2021;9:572. doi:10.3390/vaccines9060572.
- Gonzalez MP, Rios R, Pappaterra M, et al. Reactivation of acute retinal necrosis following SARS-CoV-2 Infection. Case Rep Ophthalmol Med. 2021;2021:7336488. doi:10.1155/2021/7336488.
- Soni A, Narayanan R, and Tyagi M 19 MAY , et al. Acute retinal necrosis as a presenting ophthalmic manifestation in COVID 19 recovered patients. Ocul Immunol Inflamm 29 (4) . 2021;722–725 doi:10.1080/09273948.2021.1938135.